Combined ultrasound and biochemical screening for Down's Syndrome in the first trimester: a Scottish multicentre study

Abstract

NT in combination with appropriate serum markers has the potential to detect over 80% of Down's Syndrome fetuses in early pregnancy. However, NT measurement is highly operator-dependent. It requires training, external quality control and adequate time to allow accurate measurement, otherwise suboptimal performance will result.